this link is directly from AMGEN -please read
http://www.amgen.com/media/media_pr_...leaseID=910461
Amgen Inc. buying Avidia Inc.
Newscom
September 29, 2006
Amgen Inc., a California biotechnology company, is buying Avidia Inc., which is developing a protein-based class of drugs known as Avimer.
Avidia is engineering Avimer therapeutics against multiple validated and novel targets, for use in treating inflammation, and in oncology and neurology.
Amgen will pay $290 million cash, net of existing cash balances and Amgen's existing equity stake in Avidia, and up to $90 million upon the achievement of certain milestones.
Following the completion of the transaction, Avidia will become a wholly owned subsidiary of Amgen.
Copyright 2006 by United Press International